Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Mikee3003 on Mar 15, 2021 6:53pm

Winnipeg Lab

Just listened to this on CBC.

Possibly a small fraction of this coming our way??

nml-covid-1.5946536
Comment by Mikee3003 on Mar 15, 2021 6:58pm
This sentence in the article gets me a little excited, could it be TLT?? "There is one promising candidate that has started pre-clinical trials in animal model testing, Poliquin said."
Comment by Jaro1977 on Mar 15, 2021 7:08pm
https://www.cbc.ca/news/canada/manitoba/nml-covid-1.5946536
Comment by 99942Apophis on Mar 15, 2021 7:51pm
For a list of Canadian Covid-19 clinical trials  search has 8 pages and there isn't any listing for TLD-1433  or U of M, Dr. Coombs or Theralase  Drugs and vaccines for COVID-19: List of authorized clinical trials
Comment by Mikee3003 on Mar 15, 2021 8:27pm
Currently I don't believe TLD would be considered at clinical trial stage, still at research stage?Maybe someone else can chime in on this. Thanks, Mikee
Comment by Rumpl3StiltSkin on Mar 16, 2021 10:25am
Mike, I think you answered your own question here a few posts down. pre-clinical= research stage. ;-)
Comment by Mikee3003 on Mar 16, 2021 12:16pm
Rumpl....true enough, thanks for pointing that out. Mikee
Comment by StevenBirch on Mar 15, 2021 8:28pm
Starting a trial is one of the pieces of news we are hoping to see in the near future.
Comment by ScienceFirst on Mar 15, 2021 8:33pm
You won't find any because pre-clinical trials (animal models) don't require any HC approvals. ________________________ 99942Apophis - (3/15/2021 7:51:24 PM) RE:RE:RE:Winnipeg Lab For a list of Canadian Covid-19 clinical trials  search has 8 pages and there isn't any listing for TLD-1433  or U of M, Dr. Coombs or Theralase  Drugs and vaccines for ...more  
Comment by 99942Apophis on Mar 15, 2021 8:58pm
Thank you ScienceFirst, I was under the opinion the company (TLT) would be concentrating their efforts on this Ph2 NMIBC and PH1 Brain & Lung before funding a Coronavirus vaccine since there is sufficient remedies out there all in my opinion. I would guess once TLT does go into vaccine trial it might treat the entire family of Coronavirus instead of just one strain or perhaps I don't fully ...more  
Comment by Rumpl3StiltSkin on Mar 16, 2021 10:29am
Apop, I think the possibility of some good pre-clinical 1433 data on Covid 19 would boost SP. Because of the potential of, like you've said, partnerships or Govt. grant money $$ etc. Yes, a cure for Covid, Sars, Ebola, and the common cold! Not bad!
Comment by ScienceFirst on Mar 16, 2021 7:56pm
3 winners have been announced. Here's one of them: Immune Biosolutions Receives C$13.44 Million to Develop and Biomanufacture its Promising Immunotherapy to Treat COVID-19 and its Variants SHERBROOKE, Qubec (March 16, 2021)—Immune Biosolutions, an innovative biotechnology company, receives $13.44M from the Government of Canada’s Strategic Innovation Fund (SIF) to develop its promising ...more  
Comment by Jaro1977 on Mar 16, 2021 8:33pm
 By investing in domestic biomanufacturing facilities and equipment, such as KABS Laboratories, Novocol and Immune Biosolutions are these the 3 winners?
Comment by ScienceFirst on Mar 15, 2021 8:58pm
Last press release of TLT on COVID-19 was mentioning this below, that even if 100% successful in in-vivo, we would still be months away from enrolling patients in a Ph. 1b and even further away from Ph. 1b results and then Ph. 2b enrollment.  So we're talking at least 1.5 years. Considering that current vaccines (Biontech, Moderna, etc ...) yield 95% efficacy and that TLT's one would ...more  
Comment by ScienceFirst on Mar 15, 2021 9:06pm
The only way that I could see a gain for TLT to enter this indication, aprt from being fully funded by gov. grants, would be for them to be authorized to skip a Ph. 1b because of the safety of our drug in the NMIBC indication.   As per the August 2020 press release: These drug doses demonstrated a 99.995% destruction rate of the BSL-2 coronavirus and are significantly lower ...more  
Comment by ScienceFirst on Mar 15, 2021 10:00pm
Current vaccines on the market don't kill the virus.  They protect against by preventing the virus to do its usual damages.
Comment by m8magic on Mar 15, 2021 11:25pm
over the news tonight the CBC had the Winnepeg Lab spokesman on air and the spokesman said they will not reveal the name/names of the companies or persons making strides on the covid front with innovative treatment or vaccine potential...so TLTs Coombs could very we be in the mix and could get part of the 2 billion dollar funding..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250